Skip to main content

Table 2 Blood pressure characteristics at baseline for the total study population and stratified for reaching the blood pressure treatment target goal

From: Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study

  All
n = 508
Below targetΔ
n = 58
Above targetΔ
n = 450
Systolic blood pressure (mmHg) 152 ± 27 114 ± 12 157 ± 25
Diastolic blood pressure (mmHg) 83 ± 14 68 ± 8 85 ± 13
Anti-hypertensive drug types (%)    
   ACE-inhibitor 43 60 40
   Angiotensin II-inhibitor 20 10 21
   Beta-blocker 39 31 40
   Calcium antagonist 45 22 48
   Diuretics 48 52 48
   Other* 14 7 15
Number of anti-hypertensive drug types (%)    
   0 8 9 8
   1 26 35 24
   2 28 33 28
   ≥ 3 38 23 40
  1. Systolic (SBP) and diastolic blood pressure (DBP) are presented as mean ± standard deviation (SD).
  2. Δ Below the target was defined as SBP < 130 and DBP < 80 mmHg and above the target as SBP ≥ 130 and/or DBP ≥ 80 mmHg. * Defined as the prescription of alpha blocker, vasodilator, and/or central working agent.